PMID: 15389129Sep 25, 2004Paper

Effects of vitamin K antagonist phenprocoumon on activated partial thromboplastin time measurement of direct thrombin inhibitors

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
T FenyvesiJob Harenberg

Abstract

The activated partial thromboplastin time (aPTT) is currently the most common test used to measure the anticoagulation intensity of heparins and direct thrombin inhibitors (DTIs). Vitamin K antagonists variably affect aPTT reagents. Interactions between heparin and DTIs occur during concurrent therapy. Three DTIs (lepirudin, argatroban, melagatran) and one unfractionated heparin (liquemin) were added to normal plasma (NP) samples (n = 23) and to vitamin K antagonist plasma (VKAP) samples (n = 23) of patients treated with phenprocoumon. Lepirudin and argatroban were added at concentrations from 300 to 3000 ng/ml, melagatran from 30 to 1000 ng/ml, and unfractionated heparin from 0.016 to 0.48 IU/ml. Wave parameters of clotting time and aPTT ratio curves were evaluated by multivariate analysis for inhibitors, aPTT reagents and NP and VKAP samples. Normal ranges resulting from NP samples were 34.5 +/- 1.0 s with Pathromtin SL and 33.9 +/- 0.8 s with Platelin LS. Normal ranges using VKAP were 52.8 +/- 2.6 s (Pathromtin SL) and 44.2 +/- 1.1 s (Platelin LS) (P < 0.0001). Variance analysis showed that inhibitors, plasmas (NP versus VKAP) and reagents influenced the wave characteristics of aPTT (s) (P < 0.0001) and aPTT ratios (P < 0.00...Continue Reading

References

Jan 1, 1991·Haemostasis·P Baumann, C C Heuck
Jan 1, 1991·Haemostasis·J W FentonJ M Maraganore
Jan 1, 1991·Haemostasis·J M WalengaJ Fareed
Aug 1, 1990·Journal of Clinical Pathology·J M ThomsonL Poller
Aug 12, 1986·Biochemistry·S R Stone, J Hofsteenge
Aug 11, 1981·Molecular and Cellular Biochemistry·B C Johnson
Jan 1, 1997·Seminars in Thrombosis and Hemostasis·J HarenbergD L Heene
Jan 1, 1997·Seminars in Thrombosis and Hemostasis·M J HurstingR P Schwarz
May 30, 1998·Archives of Internal Medicine·C KearonJ S Ginsberg
Nov 7, 2002·Seminars in Thrombosis and Hemostasis·Gerd HafnerMatthias Nauck
Oct 31, 2003·The New England Journal of Medicine·Sam SchulmanUNKNOWN THRIVE III Investigators
Jan 27, 2004·The Annals of Pharmacotherapy·Paul A Arpino, Robert K Hallisey

❮ Previous
Next ❯

Citations

Feb 27, 2015·Clinical Chemistry and Laboratory Medicine : CCLM·Shanshan DuJob Harenberg
Sep 1, 2005·Journal of Thrombosis and Thrombolysis·Tivadar FenyvesiIngrid Jörg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.